UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease

The Journal of neuroscience, 2001-12, Vol.21 (23), p.9112-9123

2001

Volltextzugriff (PDF)

A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S264

2015

Volltextzugriff (PDF)

Predictors of disease severity and progression in patients with Duchenne muscular dystrophy: A literature review

European journal of paediatric neurology, 2017-06, Vol.21, p.e93-e93

2017

Volltextzugriff (PDF)

P169 – 2697: A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping drugs, SRP-4045 and SRP-4053, in a master protocol for patients with Duchenne muscular dystrophy (DMD)

European journal of paediatric neurology, 2015-05, Vol.19, p.S141-S141

2015

Volltextzugriff (PDF)

Movement monitoring at home and during study visits identifies sources of variability in 6MWT performance in Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S152-S153

2016

Volltextzugriff (PDF)

Longitudinal results of magneto-inertial motion analysis in Duchenne muscular dystrophy ambulant patients

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S184-S185

2016

Volltextzugriff (PDF)

G.P.259 - A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2015-10, Vol.25, p.S263-S264

2015

Volltextzugriff (PDF)

Does Change in Patient-Reported QOL Correlate with Change in Other Clinical and MRI Measures in Early MS? Analysis of the 10-Year CHAMPIONS Cohort (P07.100)

Neurology, 2012-04, Vol.78 (Meeting Abstracts 1), p.P07-P07.100

2012

Volltextzugriff (PDF)

Identifying Patients with Relapsing-Remitting Multiple Sclerosis Who Have Aggressive Disease Characterized by Rapid Disability Progression (P05.093)

Neurology, 2012-04, Vol.78 (Meeting Abstracts 1), p.P05-P05.093

2012

Volltextzugriff (PDF)

A.O.10 - Movement monitoring at home and during study visits identifies sources of variability in 6MWT performance in Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S152-S153

2016

Volltextzugriff (PDF)

Forskolin and dopamine D1 receptor activation increase huntingtin's association with endosomes in immortalized neuronal cells of striatal origin

Neuroscience, 1999, Vol.89 (4), p.1159-1167

1999

Volltextzugriff (PDF)

Functional limits of conformation, hydrophobicity, and steric constraints in prokaryotic signal peptide cleavage regions. Wild type transport by a simple polymeric signal sequence

The Journal of biological chemistry, 1991-01, Vol.266 (2), p.1326-1334

1991

Volltextzugriff (PDF)

Peptide and Protein Synthesis by Segment Synthesis-Condensation

Science (American Association for the Advancement of Science), 1989-01, Vol.243 (4888), p.187-192

1989

Volltextzugriff (PDF)

P.328 - Longitudinal results of magneto-inertial motion analysis in Duchenne muscular dystrophy ambulant patients

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S184-S185

2016

Volltextzugriff (PDF)

Mutant Huntingtin Expression in Clonal Striatal Cells: Dissociation of Inclusion Formation and Neuronal Survival by Caspase Inhibition

The Journal of neuroscience, 1999-02, Vol.19 (3), p.964-973

1999

Volltextzugriff (PDF)

Development of Phosphorodiamidate Morpholino Oligomers (PMOs) for the Treatment of Duchenne Muscular Dystrophy (DMD) (S42.008)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Are there multiple pathways in the pathogenesis of Huntington's disease?

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 1999-06, Vol.354 (1386), p.995

1999

Volltextzugriff (PDF)

Signal peptide subsegments are not always functionally interchangeable. M13 procoat hydrophobic core fails to transport alkaline phosphatase in Escherichia coli

The Journal of biological chemistry, 1989-08, Vol.264 (24), p.14478-14485

1989

Volltextzugriff (PDF)

The fiction of informed consent

JAMA : the journal of the American Medical Association, 1976-04, Vol.235 (15), p.1579

Laforet, E G

1976

Volltextzugriff (PDF)

Analysis of huntingtin-associated protein 1 in mouse brain and immortalized striatal neurons

Journal of comparative neurology (1911), 1999-01, Vol.403 (4), p.421-430

1999

Volltextzugriff (PDF)

Forskolin and dopamine D 1 receptor activation increase Huntingtin's association with endosomes in immortalized neuronal cells of striatal origin

Neuroscience, 1999-04, Vol.89 (4), p.1159-1167

1999

Volltextzugriff (PDF)

Cecil Coggins and the war in the shadows

JAMA : the journal of the American Medical Association, 1980-04, Vol.243 (16), p.1653

Laforet, E G

1980

Volltextzugriff (PDF)

Carcinoma obstructing the trachea. Treatment by laser resection

The New England journal of medicine, 1976-04, Vol.294 (17), p.941-941

1976

Volltextzugriff (PDF)

Management of spontaneous esophageal rupture

JAMA : the journal of the American Medical Association, 1979-01, Vol.241 (2), p.134

Laforet, E G

1979

Volltextzugriff (PDF)

Treatment of esophagobronchial fistula

JAMA : the journal of the American Medical Association, 1978-06, Vol.239 (22), p.2338

Laforet, E G

1978

Volltextzugriff (PDF)

1 – 25 von 355

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(270)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(333)
Französisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease

A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

Predictors of disease severity and progression in patients with Duchenne muscular dystrophy: A literature review

P169 – 2697: A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping drugs, SRP-4045 and SRP-4053, in a master protocol for patients with Duchenne muscular dystrophy (DMD)

Movement monitoring at home and during study visits identifies sources of variability in 6MWT performance in Duchenne muscular dystrophy

Longitudinal results of magneto-inertial motion analysis in Duchenne muscular dystrophy ambulant patients

G.P.259 - A novel clinical trial design to evaluate the efficacy and safety of two exon-skipping PMOs, SRP-4045 and SRP-4053, in patients with Duchenne muscular dystrophy

Does Change in Patient-Reported QOL Correlate with Change in Other Clinical and MRI Measures in Early MS? Analysis of the 10-Year CHAMPIONS Cohort (P07.100)

Identifying Patients with Relapsing-Remitting Multiple Sclerosis Who Have Aggressive Disease Characterized by Rapid Disability Progression (P05.093)

A.O.10 - Movement monitoring at home and during study visits identifies sources of variability in 6MWT performance in Duchenne muscular dystrophy

Forskolin and dopamine D1 receptor activation increase huntingtin's association with endosomes in immortalized neuronal cells of striatal origin

Functional limits of conformation, hydrophobicity, and steric constraints in prokaryotic signal peptide cleavage regions. Wild type transport by a simple polymeric signal sequence

Peptide and Protein Synthesis by Segment Synthesis-Condensation

P.328 - Longitudinal results of magneto-inertial motion analysis in Duchenne muscular dystrophy ambulant patients

Mutant Huntingtin Expression in Clonal Striatal Cells: Dissociation of Inclusion Formation and Neuronal Survival by Caspase Inhibition

Development of Phosphorodiamidate Morpholino Oligomers (PMOs) for the Treatment of Duchenne Muscular Dystrophy (DMD) (S42.008)

Are there multiple pathways in the pathogenesis of Huntington's disease?

Signal peptide subsegments are not always functionally interchangeable. M13 procoat hydrophobic core fails to transport alkaline phosphatase in Escherichia coli

The fiction of informed consent

Analysis of huntingtin-associated protein 1 in mouse brain and immortalized striatal neurons

Forskolin and dopamine D 1 receptor activation increase Huntingtin's association with endosomes in immortalized neuronal cells of striatal origin

Cecil Coggins and the war in the shadows

Carcinoma obstructing the trachea. Treatment by laser resection

Management of spontaneous esophageal rupture

Treatment of esophagobronchial fistula

Suchergebnisse filtern